Physician profile
Ramanath Rao
NPI 1780791251
$4,927.38
in general payments reported to CMS, 2019-2025
37 companies · $736 in 2025
The $736 reported for 2025 was more than what 84% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $676 · 2020: $584 · 2021: $845 · 2022: $749 · 2023: $486 · 2024: $850 · 2025: $736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,055 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,054.99 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $627.32 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $464.51 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $441.48 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $392.82 | 2019-2025 | Jardiance |
| Pfizer INC. | $349.86 | 2019-2025 | |
| Abbott Laboratories | $277.13 | 2019-2022 | |
| Boston Scientific Corporation | $271.96 | 2019-2025 | Varithena Administration Pack, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $265.29 | 2021-2025 | Micra, Intellis Adaptivestim, Aurora Ev-Icd Mri Surescan |
| E.R. Squibb & Sons, L.L.C. | $248.10 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $207.87 | 2021-2025 | Verquvo |
| Edwards Lifesciences Corporation | $178.17 | 2025 | Sapien 3 Ultra Resilia |
| Chiesi USA, INC. | $113.12 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $96.09 | 2025 | Onpattro |
| Kestra Medical Technology Services, INC. | $81.89 | 2024 | Assure Wcd |
| Inari Medical, INC. | $77.80 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramanath Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.